4th Pediatric Infectious Diseases Conference
 
 
Home  Back   ISSN 0973 - 0958
 
User name :
Password :
Follow Us : Follow On Facebook Follow On Twitter Follow On Youtube
Specialist Answers
Question
Can you please tell me the latest recommendation of RNTCP in children? According to the WHO recommendation 2003, category I & III seem to be the same as per treatment.... which was not so in previous year recommendations. Please opine!
Answer
Category 1 (New sputum smear-positive PTB OR Seriously ill extra-pulmonary TB): The intensive phase consists of Isoniazid, Rifampicin, Pyrazinamide and Ethambutol to be given under direct observation thrice a week on alternate days for 2 months (24 doses). The continuation phase consists of 4 months (18 weeks; 54 doses) of Isoniazid and Rifampicin given thrice a week on alternate days - the first dose of every weekly blister being directly observed.

Category II (Re-treatment Cases): 5 drugs for 2 months (including streptomycin) and INH, Rifampicin, Ethambutol and Pyrizinamide for 1 month followed by 5 months of INH Rifampicin and Ethambutol.

Category III (Sputum smear-negative and extra-pulmonary TB, not seriously ill): 2 months of INH, Rifampicin and Pyrizamide followed by 4 months of INH and Rifampicin.

Continuation phase of treatment in TB meningitis and spinal TB with neurological complications should be given for 6 - 7 months, extending the total duration of treatment to 8 - 9 months.

Asymptomatic children under 6 years of age, exposed to an adult with infectious (smearpositive)
tuberculosis from within the same household, are to be given 6 months of
Isoniazid (5 mg per kg daily) as chemoprophylaxis.
 
 
 
Pedi Poll
Today's Poll
Should teicoplannin, colistin be used in case of neonatal sepsis where culture does not reveal any organism_?
No, it should be used only after drug sensitivity report
Yes, under guidance of an infectious disease expert
Educational Section
 
Disclaimer:
The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
 
copyright ©2011 website design & development by Levioza
Follow Us
Follow us on :
Folllow Us